17 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 3 news categories, from Jun 24, 2026 through Jul 30, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
Medicare now provides access to GLP-1 weight-loss drugs as utilization rates among U.S. adults reach one in eight.
Research suggests a link between oral health and overall well-being
Patients aged six and older now have access to SIMTRIYO, the first new-class ADHD medication approved by the FDA in decades.
An FDA panel vote on peptides has sparked concerns regarding a potential surge in prescriptions for these compounds.
Healthcare stocks are drawing investor attention as some assets average 128% forward EPS growth amidst a broader market rotation.
OpenAI has expanded access to its new ChatGPT Health tool, prompting market reactions and legal scrutiny.
CVS Pharmacy is expanding its services to include prescription medications for pets nationwide.
Healthcare leaders are balancing the integration of advanced AI diagnostic tools with the necessity of maintaining human-centric patient care.
Rising inflation and aging-related costs are forcing a significant portion of Americans to skip or delay essential medical care.
Medical experts are highlighting the critical role of early detection and robotic surgery as prostate cancer cases rise beyond metropolitan areas.
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.
Emerging Alzheimer’s drug candidates are generating global attention as researchers and health advocates evaluate their potential to stop the disease.
Rising demand for GLP-1 weight-loss medications is straining budgets and prompting insurers and employers to limit coverage.
U.S. consumer inflation expectations reached a three-year high in June, driven by mounting anxieties over the costs of rent and healthcare.
New diagnostic technologies recommended by NICE may soon allow GPs to identify endometriosis, potentially slashing long wait times for patients.
The Education Department is introducing new repayment benefits and interest rate reductions for federal student loan borrowers.